Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma-Reference-Cited by-同舟云学术

Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma

Published:2013-09 Issue:3 Volume:24 Page:331-346
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Bhat Krishna P.L.,Balasubramaniyan Veerakumar,Vaillant Brian,Ezhilarasan Ravesanker,Hummelink Karlijn,Hollingsworth Faith,Wani Khalida,Heathcock Lindsey,James Johanna D.,Goodman Lindsey D.,Conroy Siobhan,Long Lihong,Lelic Nina,Wang Suzhen,Gumin Joy,Raj Divya,Kodama Yoshinori,Raghunathan Aditya,Olar Adriana,Joshi Kaushal,Pelloski Christopher E.,Heimberger Amy,Kim Se Hoon,Cahill Daniel P.,Rao Ganesh,Den Dunnen Wilfred F.A.,Boddeke Hendrikus W.G.M.,Phillips Heidi S.,Nakano Ichiro,Lang Frederick F.,Colman Howard,Sulman Erik P.,Aldape Kenneth

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference54 articles.

1. Chemokine signaling via the CXCR2 receptor reinforces senescence;Acosta;Cell,2008

2. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response;Bao;Nature,2006

3. Inflammation meets cancer, with NF-κB as the matchmaker;Ben-Neriah;Nat. Immunol.,2011

4. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma;Bhat;Genes Dev.,2011

5. Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas;Bredel;J. Clin. Oncol.,2006

Cited by 864 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoxia-driven heterogeneous expression of α5 integrin in glioblastoma stem cells is linked to HIF-2α;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-12

2. Targeted reprogramming of tumor-associated macrophages for overcoming glioblastoma resistance to chemotherapy and immunotherapy;Biomaterials;2024-12

3. FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair;Journal of Neuro-Oncology;2024-09-09

4. FACT inhibitor CBL0137, administered in an optimized schedule, potentiates radiation therapy for glioblastoma by suppressing DNA damage repair;2024-09-09

5. Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis;Scientific Reports;2024-09-05